EC Number | Activating Compound | Comment | Organism | Structure |
---|---|---|---|---|
2.7.11.31 | metformin | improves cardiac structure and function, which is associated with increases in AMPK and endothelial nitric oxide synthase phosphorylation, as well as increased peroxisome proliferator-activated receptor-gamma coactivator (PGC)-1alpha expression in cardiac myocytes. Cardioprotective effects of metformin are ablated in mice lacking functional AMPK or nitric oxide synthase | Mus musculus |
EC Number | Cloned (Comment) | Organism |
---|---|---|
2.7.11.31 | cardiac-specific transgenic mice overexpressing a dominant-negative AMPKalpha2 subunit | Mus musculus |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.7.11.31 | Mus musculus | - |
C57BL/6J mice | - |
2.7.11.31 | Mus musculus C57/BL6J | - |
C57BL/6J mice | - |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.7.11.31 | cardiac myocyte | - |
Mus musculus | - |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.7.11.31 | AMP-activated protein kinase | - |
Mus musculus |
2.7.11.31 | AMPK | - |
Mus musculus |